The Surgical Treatment of Type II Diabetes Mellitus: Changes in HOMA Insulin Resistance in the First Year Following Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) and Laparoscopic Adjustable Gastric Banding (LAGB)

被引:32
作者
Ballantyne, Garth H. [2 ]
Wasielewski, Annette [2 ]
Saunders, John K. [1 ]
机构
[1] NYU, Dept Gen Surg, New York, NY 10010 USA
[2] Hackensack Univ Med Ctr, Sect Minimally Invas Surg, Hackensack, NJ 07601 USA
关键词
Bariatric surgery; Weight loss surgery; Laparoscopic gastric bypass; Laparoscopic adjustable gastric banding; Type II diabetes mellitus; Insulin resistance; Hemoglobin A1c; HOMA IR; Morbid obesity; WEIGHT-LOSS; BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; ENTEROINSULAR AXIS; PEPTIDE YY(3-36); OBESITY SURGERY; GLUCOSE; YY(1-36);
D O I
10.1007/s11695-009-9870-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Bariatric operations significantly improve glucose metabolism, decrease insulin resistance, and lead to clinical resolution of type II diabetes mellitus in many patients. The mechanisms that achieve these clinical outcomes, however, remain ill defined. Moreover, the relative impact of various operations on insulin resistance remains vigorously contested. Consequently, the purpose of this study was to compare directly the impact of laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB) on hemoglobin A1c (HbA1c) levels and insulin resistance in comparable groups of morbidly obese patients. Data were entered prospectively into our bariatric surgery database and reviewed retrospectively. Patients selected operations. Principle outcome variables were percent excess weight loss (%EWL), HbA1c, and homeostatic model assessment for insulin resistance (HOMA IR). The number of follow-up visits for 111 LAGB patients was 263 with a median of 162 days (17-1,016) and 291 follow-up visits for 104 LRYGB patients for a median of 150 days (8-1,191). Preoperative height, weight, body mass index, age, sex, race, comorbidities, fasting glucose, insulin, HbA1c, and HOMA IR were similar for both groups. In particular, the number of patients who were diabetics and those receiving insulin and other hypoglycemic agents were similar among the two groups. The LAGB patients lost significantly less weight than the LRYGB patients (24.6% compared to 44.0% EWL). LAGB reduced HbA1c from 5.8% (2-13.8) to 5.6% (0.3-12.3). LRYGB reduced HbA1c from 5.9% (2.0-12.3) to 5.4% (0.1-9.8). LAGB reduced HOMA IR from 3.6 (0.8-39.2) to 2.3 (0-55) and LRYGB reduced HOMA IR from 4.4 (0.6-56.5) to 1.4 (0.3-15.2). Postoperative HOMA IR correlated best with %EWL. Indeed, regression equations were essentially identical for LAGB and LRYGB for drop in %EWL versus postoperative HOMA IR. Percent excess weight loss significantly predicts postoperative insulin resistance (HOMA IR) during the first year following both LRYGB and LAGB.
引用
收藏
页码:1297 / 1303
页数:7
相关论文
共 34 条
  • [1] Short-term changes in insulin resistance following weight loss surgery for morbid obesity: Laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass
    Ballantyne, G. H.
    Farkas, D.
    Laker, S.
    Wasielewski, A.
    [J]. OBESITY SURGERY, 2006, 16 (09) : 1189 - 1197
  • [2] Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery
    Ballantyne, Garth H.
    [J]. OBESITY SURGERY, 2006, 16 (06) : 795 - 803
  • [3] Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions
    Ballantyne, GH
    [J]. OBESITY SURGERY, 2006, 16 (05) : 651 - 658
  • [4] Changes in insulin resistance following bariatric surgery and the adipoinsular axis: Role of the adipocytokines, leptin, adiponectin and resistin
    Ballantyne, GH
    Gumbs, A
    Modlin, IM
    [J]. OBESITY SURGERY, 2005, 15 (05) : 692 - 699
  • [5] Patient characteristics impacting excess weight loss following laparoscopic adjustable gastric banding
    Chau, WY
    Schmidt, HJ
    Kouli, W
    Davis, D
    Wasielewski, A
    Ballantyne, GH
    [J]. OBESITY SURGERY, 2005, 15 (03) : 346 - 350
  • [6] A case-controlled matched-pair cohort study of laparoscopic Roux-en-Y gastric bypass and Lap-Band® patients in a single US center with three-year follow-up
    Cottam, DR
    Atkinson, J
    Anderson, A
    Grace, B
    Fisher, B
    [J]. OBESITY SURGERY, 2006, 16 (05) : 534 - 540
  • [7] Glycemic control after bariatric surgery - Comment
    Deitel, M
    [J]. OBESITY SURGERY, 1996, 6 (04) : 349 - 350
  • [8] DEITEL M, 1991, OBES SURG, V1, P113
  • [9] Changes in comorbidities and improvements in quality of life after LAP-BAND placement
    Dixon, JB
    O'Brien, PE
    [J]. AMERICAN JOURNAL OF SURGERY, 2002, 184 (6B) : 51S - 54S
  • [10] Adjustable gastric banding and conventional therapy for type 2 diabetes - A randomized controlled trial
    Dixon, John B.
    O'Brien, Paul E.
    Playfair, Julie
    Chapman, Leon
    Schachter, Linda M.
    Skinner, Stewart
    Proietto, Joseph
    Bailey, Michael
    Anderson, Margaret
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03): : 316 - 323